MoneyWorks4Me

A decent increase of about 45.35% in the sales to Rs. 5160.00 millions was observed for the quarter ended March 2026. The sales figure stood at Rs. 3550.00 millions during the year-ago period.Net Profit for the quarter ended March 2026 zoomed to 317.50% from Rs. 400.00 millions to Rs. 1670.00  millions.The company reported a good operating profit of 2160.00 millions compared to 1200.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202603 202503 % Var 202603 202503 % Var 202603 202503 % Var
Sales 5160.00 3550.00 45.35 17390.00 14020.00 24.04 17390.00 14020.00 24.04
Other Income 550.00 140.00 292.86 1370.00 550.00 149.09 1370.00 550.00 149.09
PBIDT 2160.00 1200.00 80.00 6540.00 3550.00 84.23 6540.00 3550.00 84.23
Interest 410.00 400.00 2.50 1760.00 1990.00 -11.56 1760.00 1990.00 -11.56
PBDT 2100.00 800.00 162.50 5030.00 1560.00 222.44 5030.00 1560.00 222.44
Depreciation 430.00 400.00 7.50 1860.00 1680.00 10.71 1860.00 1680.00 10.71
PBT 1670.00 400.00 317.50 3170.00 -120.00 -2741.67 3170.00 -120.00 -2741.67
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 1670.00 400.00 317.50 3170.00 -120.00 -2741.67 3170.00 -120.00 -2741.67
Equity 810.00 810.00 0.00 810.00 810.00 0.00 810.00 810.00 0.00
PBIDTM(%) 41.86 33.80 23.84 37.61 25.32 48.52 37.61 25.32 48.52
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..